Estudio ARAPOC: prevalencia de síntomas respiratorios y enfermedad obstructiva crónica en población general

Alijarde, M. José Bruscas; Toña, Karlos Naberan; Sánchez, Marta; Dronda, Salvador Bello

doi:10.1016/j.aprim.2014.07.006

Cited by 6 publications

(3 citation statements)

References 20 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Previous studies have shown that multimorbidity is generally more prevalent in women than in men. 4 Asthma tends to be more prevalent in women than in men, 27 whereas historically COPD tended to have the opposite gender balance, 28 although there is evidence that this trend is starting to reverse. 29 , 30 To date, however, there is no clear evidence of a difference in the rates of comorbidity by gender, specifically in those with asthma.…”

Section: Gendermentioning

confidence: 99%

Managing multimorbidity in primary care in patients with chronic respiratory conditions

Morrison

Agur

Mercer

et al. 2016

npj Prim Care Resp Med

View full text Add to dashboard Cite

The term multimorbidity is usually defined as the coexistence of two or more chronic conditions within an individual, whereas the term comorbidity traditionally describes patients with an index condition and one or more additional conditions. Multimorbidity of chronic conditions markedly worsens outcomes in patients, increases treatment burden and increases health service costs. Although patients with chronic respiratory disease often have physical comorbidities, they also commonly experience psychological problems such as depression and anxiety. Multimorbidity is associated with increased health-care utilisation and specifically with an increased number of prescription drugs in individuals with multiple chronic conditions such as chronic obstructive pulmonary disease. This npj Primary Care Respiratory Medicine Education Section case study involves a patient in a primary care consultation presenting several common diseases prevalent in people of this age. The patient takes nine different drugs at this moment, one or more pills for each condition, which amounts to polypharmacy. The problems related with polypharmacy recommend that a routine medication review by primary care physicians be performed to reduce the risk of adverse effects of polypharmacy among those with multiple chronic conditions. The primary care physician has the challenging role of integrating all of the clinical problems affecting the patient and reviewing all medicaments (including over-the-counter medications) taken by the patient at any point in time, and has the has the key to prevent the unwanted consequences of polypharmacy. Multimorbid chronic disease management can be achieved with the use of care planning, unified disease templates, use of information technology with appointment reminders and with the help of the wider primary care and community teams.

show abstract

Section: Gendermentioning

confidence: 99%

Managing multimorbidity in primary care in patients with chronic respiratory conditions

Morrison

Agur

Mercer

et al. 2016

npj Prim Care Resp Med

View full text Add to dashboard Cite

show abstract

“…Tamayo-Marco et al ( 56 ) reported a proportion of unknown cases of diabetes nearly 50% in their Aragonese sample population. It is also worth mentioning that, in the specific case of Aragon, there has also been talk of under-diagnosis of other NCDs such as Chronic Obstructive Pulmonary Disease ( 57 ) and depression ( 58 ). Regarding the VMP, in Spain there are previous initiatives such as the Atlas of VMP in the Spanish National Health System ( 59 ).…”

Section: Discussionmentioning

confidence: 99%

Spatial patterns in sociodemographic factors explain to a large extent the prevalence of hypertension and diabetes in Aragon (Spain)

2023

View full text Add to dashboard Cite

IntroductionThe global burden of multi-morbidity has become a major public health challenge due to the multi stakeholder action required to its prevention and control. The Social Determinants of Health approach is the basis for the establishment of health as a cross-cutting element of public policies toward enhanced and more efficient decision making for prevention and management.ObjectiveTo identify spatially varying relationships between the multi-morbidity of hypertension and diabetes and the sociodemographic settings (2015–2019) in Aragon (a mediterranean region of Northeastern Spain) from an ecological perspective.Materials and methodsFirst, we compiled data on the prevalence of hypertension, diabetes, and sociodemographic variables to build a spatial geodatabase. Then, a Principal Component Analysis (PCA) was performed to derive regression variables, i.e., aggregating prevalence rates into a multi-morbidity component (stratified by sex) and sociodemographic covariate into a reduced but meaningful number of factors. Finally, we applied Geographically Weighted Regression (GWR) and cartographic design techniques to investigate the spatial variability of the relationships between multi-morbidity and sociodemographic variables.ResultsThe GWR models revealed spatial explicit relationships with large heterogeneity. The sociodemographic environment participates in the explanation of the spatial behavior of multi-morbidity, reaching maximum local explained variance (R2) of 0.76 in men and 0.91 in women. The spatial gradient in the strength of the observed relationships was sharper in models addressing men’s prevalence, while women’s models attained more consistent and higher explanatory performance.ConclusionModeling the prevalence of chronic diseases using GWR enables to identify specific areas in which the sociodemographic environment is explicitly manifested as a driving factor of multi-morbidity. This is step forward in supporting decision making as it highlights multi-scale contexts of vulnerability, hence allowing specific action suitable to the setting to be taken.

show abstract

“…Para nuestros trabajos de fin de grado de medicina, hemos realizado un estudio descriptivo de la correlación entre los indicadores de prevalencia del tabaquismo y de la morbimortalidad por la enfermedad pulmonar obstructiva crónica (EPOC) en España durante 20 años, a partir de los artículos publicados en su revista1, 2. Hemos evaluado, también, la evolución de los mismos indicadores por cardiopatía isquémica en España, utilizando los datos del portal estadístico del Sistema Nacional de Salud 3 , y la información de diferentes fuentes: Encuesta Nacional de Salud de España (ENSE), Encuesta Europea de Salud (EES), Conjunto Mínimo Básico de Datos (CMBD) y Defunciones Según Causa de Muerte (DSCM).…”

unclassified

Tabaquismo y morbimortalidad durante 20 años en España: a propósito de la enfermedad pulmonar obstructiva crónica y de la cardiopatía isquémica

Artacho¹,

Valle²,

Vicente³

2017

Atención Primaria

View full text Add to dashboard Cite

Estudio ARAPOC: prevalencia de síntomas respiratorios y enfermedad obstructiva crónica en población general

Abstract: The high prevalence of COPD and the significant level of underdiagnoses lead to believe that early diagnosis of this disease is still a pending issue. New strategies need to be developed to resolve this problem.

Cited by 6 publications

References 20 publications

Managing multimorbidity in primary care in patients with chronic respiratory conditions

Managing multimorbidity in primary care in patients with chronic respiratory conditions

Spatial patterns in sociodemographic factors explain to a large extent the prevalence of hypertension and diabetes in Aragon (Spain)

Tabaquismo y morbimortalidad durante 20 años en España: a propósito de la enfermedad pulmonar obstructiva crónica y de la cardiopatía isquémica

Contact Info

Product

Resources

About